PSEN1 and Alzheimer disease: These findings strongly support the hypothesis that Aβ42/40 ratio is tightly linked to the conformation of the PS1 molecule, thus making allosteric modulation of “pathogenic” conformation of PS1 an attractive target of therapeutic intervention in Alzheimer's disease.